XML 75 R56.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Related Parties Transactions (Details) - USD ($)
 1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Jul. 27, 2021
Jul. 01, 2020
Jun. 16, 2022
Mar. 31, 2024
Jun. 30, 2023
Dec. 31, 2023
Dec. 31, 2022
Nov. 17, 2023
Mar. 31, 2023
Feb. 23, 2023
Dec. 01, 2021
Sep. 07, 2021
Related Parties Transactions [Line items]                        
Loans bear interest rate     5.00%                  
Additional working capital percentage     6.40%                  
Conversion price, description       The Company may convert the Note at any time into shares of Rgene’s common stock at either (i) a fixed conversion price equal to $1.00 per share or (ii) 20% discount of the stock price of the then most recent offering, whichever is lower; the conversion price is subject to adjustment as set forth in the Note. The Note includes standard events of default, as well as a cross default provision pursuant to which a breach of the Service Agreement will trigger an event of default under the convertible note if not cured after 5 business days of written notice regarding the breach is provided.   The Company may convert the Note at any time into shares of Rgene’s common stock at either (i) a fixed conversion price equal to $1.00 per share or (ii) 20% discount of the stock price of the then most recent offering, whichever is lower; the conversion price is subject to adjustment as set forth in the Note. The Note includes standard events of default, as well as a cross-default provision pursuant to which a breach of the Service Agreement will trigger an event of default under the convertible note if not cured after 5 business days of written notice regarding the breach is provided.            
Outstanding loan balance       $ 500,000   $ 500,000            
Accrued interest       38,819   38,819 $ 13,819          
Due from BHK       123,363   113,516 112,822          
Principal amount           346,565   $ 1,200,000   $ 3,704,167    
Outstanding balance amount           147,875 188,753          
Outstanding principal and accrued interest       145,858   152,382 151,450          
Interest expenses       $ 5,938   $ 4,896            
Balance of outstanding loans             1,000,000          
Loan agreement amount             507,000          
Interest rate           6.50%            
Expected credit losses           $ 953,499 865,477          
Interest expenses           40,878            
Interest expenses           $ 20,094 21,378          
Bear Interest Rate [Member]                        
Related Parties Transactions [Line items]                        
Loan agreement, description       The advances bear interest rate of 12% per annum.   The advances bear interest rate from 12% to 13.6224% per annum.            
BHK Co Development Agreement [Member]                        
Related Parties Transactions [Line items]                        
Loan agreement, description       The development costs shall be shared 50/50 between BHK and the Company. Under the term of the agreement, BioLite issued relevant development cost to BHK.   The development costs shall be shared 50/50 between BHK and the Company. Under the term of the agreement, BioLite issued relevant development cost to BHK.            
Jiangs [Member]                        
Related Parties Transactions [Line items]                        
Outstanding balance amount       $ 152,501   $ 19,789 19,789          
Rgene [Member]                        
Related Parties Transactions [Line items]                        
Other receivables           2,667            
Outstanding loan balance           541,486 513,819          
BioFirst (Australia) [Member]                        
Related Parties Transactions [Line items]                        
Expected credit losses           839,983 752,655          
Related Party [Member]                        
Related Parties Transactions [Line items]                        
Other receivables       2,553   2,667            
Outstanding loan balance       887,937   747,573 513,819          
Fees paid       301,972   173,132 359,992          
Balance of outstanding loans           500,000 500,000          
Expected credit losses       $ 963,346   $ 953,499            
BioFirst [Member]                        
Related Parties Transactions [Line items]                        
Loan agreement, description       BioFirst which bears interest at 12% per annum for the use of working capital   The advances bear interest 1% per month (or equivalent to 12% per annum).            
Outstanding loan balance       $ 346,565   $ 206,087            
Accrued interest       0   0            
Maturity date                     Nov. 30, 2022  
Due to a Director [Member]                        
Related Parties Transactions [Line items]                        
Fees paid       $ 3,613   $ 961 961   $ 3,613      
Several Loan Agreements [Member] | AUSTRALIA                        
Related Parties Transactions [Line items]                        
Outstanding balance amount         $ 25,500              
Loan agreement amount                 $ 88,091      
Convertible Debt [Member]                        
Related Parties Transactions [Line items]                        
Principal amount     $ 1,000,000                  
Jiangs [Member] | Minimum [Member]                        
Related Parties Transactions [Line items]                        
Loans bear interest rate       0.00%   0.00%            
Jiangs [Member] | Maximum [Member]                        
Related Parties Transactions [Line items]                        
Loans bear interest rate       1.00%   1.00%            
BioFirst (Australia) [Member]                        
Related Parties Transactions [Line items]                        
Accrued interest           $ 158,798 92,171          
Research and development cost   $ 361,487                    
Interest rate   6.50%                    
Loan agreement amount                     $ 250,000 $ 67,873
Repaid loan $ 249,975                      
Interest rate percentage                     6.50%  
Accrued interest           681,185            
Research fee             $ 660,484          
Director [Member]                        
Related Parties Transactions [Line items]                        
Fees paid           $ 961